Name: 글로벌 시력 관리 기기 시장 - 2023-2030 - Prime research
SKU: DMMD96
Availability: InStock

보고서 요약(국문)

시장 개요
전 세계 시력 관리 기기 시장 규모는 2022년 124억 달러였으며, 2030년까지 247억 8천만 달러에 이를 것으로 예상됩니다. 예측 기간(2023~2030년) 동안 연평균 성장률(CAGR)은 12.7%입니다.
시력 관리 기기는 시력을 향상시키고 유지하는 데 사용되는 의료 기기입니다. 이러한 기기는 안와에 외과적으로 영구적으로 삽입되거나 일시적으로 사용될 수 있습니다. 시력 관리 기기는 처방전 없이 또는 처방전을 통해 구입할 수 있으며, 장기간 사용할 수 있습니다.
시장 동향
전 세계 시력 관리 기기 시장 성장을 견인하는 주요 요인은 녹내장, 황반변성(AMD), 백내장과 같은 안과 질환 발병률 증가로 인한 시력 관리 기기 수요 증가, 기술 발전 및 신제품 출시입니다.
시력 관리 기기에 대한 인식 제고 노력과 첨단 기술을 적용한 새로운 시력 관리 기기의 등장으로 시장 성장이 더욱 가속화될 것으로 예상됩니다.

시력 관리 기기 시장은 기술 발전, 고령 인구 증가, 연구 개발 투자 증가, 녹내장, 백내장, 황반변성(AMD)과 같은 안과 질환 증가, 최신 기술을 활용한 신제품 개발, 그리고 신흥 시장의 의료 인프라 개선에 힘입어 성장하고 있습니다.
시력 관리 기기는 약물 전달 및 미용 목적으로 사용됩니다. 이러한 기기의 사용이 증가함에 따라 정부의 지원과 자금 투입도 늘어나고 있습니다. 이러한 자금은 인공수정체, 안과용 레이저, 녹내장 배액 장치와 같은 시력 관리 기기 제품 생산에 도움이 될 것입니다. 안과 질환 증가로 인해 이러한 기기 시장은 전 세계적으로 성장하고 있습니다. 또한 주요 업체들의 기술적으로 진보된 제품 출시도 시장 성장에 중요한 역할을 할 것으로 예상됩니다.
다양한 신제품 출시, 연구 조사, 그리고 시력 관리 기기와 관련된 인식 개선 활동 또한 시장 성장에 기여하고 있습니다. 예를 들어, 2022년 8월, 이식형 렌즈 및 전달 시스템 설계 및 공급업체인 STAAR Surgical Company는 배우 겸 가수인 조 조나스와 새로운 파트너십을 발표하며, 난시 및 근시 교정을 위해 개발된 FDA 승인 시력 교정 렌즈인 최신 이식형 콜라머 렌즈 EVO Visian에 대한 인식을 제고했습니다.
제품 리콜 및 시력 교정 기기 승인과 관련된 엄격한 규제는 시장 성장을 저해할 것으로 예상됩니다.
시력 교정에 사용되는 여러 기기의 승인에 대한 엄격한 규칙 및 규정은 시력 교정 기기 시장 성장을 저해하는 주요 요인입니다. 다양한 요구 사항을 충족해야 하므로 이러한 이식물의 전체 비용이 증가합니다. 제품에 사용되는 장기의 민감성으로 인한 높은 비용과 위험은 시장 성장을 저해할 가능성이 높습니다.
시장 리콜 또한 시장 성장을 제한하는 주요 요인입니다. 누출이나 합병증으로 인해 여러 건의 리콜이 발생하고 있습니다. 예를 들어, 2022년 10월 로슈는 제조상의 문제로 임플란트 제품인 수스비모(Susvimo)를 리콜했습니다. 수스비모는 습성 황반변성 환자의 눈에 라니비주맙을 전달하는 승인된 임플란트입니다. 전달 장치의 격막 또는 밀봉 부분에 제조상의 문제가 있어 약물 누출을 막지 못했습니다.
COVID-19 영향 분석
코로나19 팬데믹은 전 세계 재정 전망, 운영 및 위기 대응 전략에 부정적인 영향을 미쳤습니다. 특히 의료 산업은 심각한 타격을 입었으며, 시력 관리 기기 시장은 이로 인해 막대한 손실을 경험했습니다. 주요 제조업체들은 다양한 연구 및 임상 시험을 시작했으며, 전 세계적으로 다양한 계획, 제품 출시, 협력 및 합병이 진행되어 시장 성장을 촉진하고 있습니다. 예를 들어, 2020년 7월 임플란트 렌즈 및 전달 시스템 설계 및 공급업체인 STAAR Surgical Company는 노안 교정을 위한 혁신적인 임플란트 콜라머 렌즈인 EVO Viva/EVO Visian ICL이 CE 마크를 획득했다고 발표했습니다.

세그먼트 분석
인공수정체 부문은 예측 기간(2022-2029년) 동안 가장 빠른 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.
인공수정체 부문은 전 세계 시력 관리 기기 시장에서 가장 큰 시장 점유율을 차지하고 있습니다. 전 세계 시력 관리 기기 시장은 제품 유형별로 인공수정체, 안경, 콘택트렌즈, 녹내장 배액 장치, 안과용 레이저, 일반의약품 안과용품/보조제 및 기타 제품으로 세분화됩니다. 인공수정체 부문은 다른 임플란트 또는 기기에 비해 고유한 장점, 지속적인 기술 발전 및 신제품 출시로 인해 가장 큰 시장 점유율을 확보하고 있습니다.
인공수정체는 근시 또는 백내장 치료를 위해 눈에 이식하는 인공 수정체입니다. 수술 중 제거된 눈의 자연 수정체를 대체하여 원거리 또는 근거리 시력을 회복시켜 줍니다. 이러한 수정체는 조절형, 단초점형, 다초점형, 난시 교정형 등 다양한 유형이 있습니다. 백내장은 실명의 주요 원인 중 하나이며, 이러한 인공 수정체를 이용한 수술로 치료할 수 있습니다.

인공수정체는 근시 또는 백내장 치료를 위해 눈에 이식하는 인공 수정체입니다. 규제 승인 증가, 기술 발전, 신제품 출시, 연구/임상 시험 진행 등이 시장 성장을 견인하고 있습니다. 예를 들어, 존슨앤존슨 메드테크 산하 안과 전문 기업인 존슨앤존슨 비전은 2022년 9월, 인텔리라이트(InteliLight) 기술이 적용된 혁신적인 인공수정체인 TECNIS Symphony OptiBlue를 출시하여 노안 교정을 시작했습니다. 심도 있는 초점을 제공하는 이 렌즈는 인텔리라이트 포트폴리오에 포함된 하이브리드 렌즈인 TECNIS Synergy 인공수정체와 함께 안경 없이도 시력을 교정할 수 있도록 지원합니다. 이 렌즈는 더 많은 환자에게 노안 교정 효과를 제공하며, 저조도 환경에서의 우수한 성능과 뛰어난 대비를 자랑합니다.

지역 분석
북미는 전 세계 시력 관리 기기 시장에서 가장 큰 시장 점유율을 차지하고 있습니다.

북미는 풍부한 인구, 우수한 의료 인프라, 높은 소득 수준을 바탕으로 전 세계 시력 관리 기기 시장을 주도하고 있습니다. 미국 내 의료비 지출 증가로 인해 시장은 예측 기간 동안 비교적 완만한 성장세를 보일 것으로 예상됩니다. 이 시장의 상당한 규모는 높은 의료비 지출에 기인합니다.
의료비 지출 증가와 사람들의 인식 제고 또한 이 지역 시장 성장에 기여하고 있습니다. 다양한 안과 질환에 대한 시력 관리 기기 적용의 발전, 이 지역 내 제약 회사 증가, 정부 승인, 그리고 주요 업체들의 존재는 시력 관리 기기 시장 성장에 기여하고 있습니다.
또한, 제품 출시 건수의 증가도 시장 성장에 중요한 역할을 합니다. 이 지역에서는 많은 주요 개발, 기술 발전, 협력 및 계약이 이루어지고 있습니다. 예를 들어, 안과 질환 전문 기업인 존슨앤존슨 비전은 2020년 8월 백내장 치료용 인공수정체인 TECNIS Eyhance와 TECNIS Synergy가 캐나다 보건부의 승인을 받아 캐나다 시장에서 판매될 예정이라고 발표했습니다.
경쟁 환경
시력 관리 기기 시장은 국내외 기업들의 존재로 인해 경쟁이 매우 치열합니다. 노바티스(Novartis Inc.), 쿠퍼 비전(Cooper Vision), 존슨앤존슨 서비스(Johnson & Johnson Services, Inc.), 스타 서지컬(STAAR Surgical), 바슈앤롬(Bausch & Lomb Incorporated), 칼 자이스(Carl Zeiss), 오프텍(Ophtec BV), 모르처(MORCHER GmbH), 사필로 그룹(Safilo Group S.p.A), 에실로룩소티카(EssilorLuxottica) 등 주요 기업들이 신제품 출시, 인수합병, 파트너십, 협력 등 다양한 성장 전략을 통해 시장 성장에 기여하고 있습니다. 예를 들어, 2022년 7월에는 안과 전문 기업인 바슈앤롬과 안과 의료기기 회사인 사노쿨리스(Sanoculis)가 녹내장 분야의 미충족 수요에 집중하기 위한 전략적 협약을 발표했습니다.

노바티스(Novartis AG)
개요: 노바티스는 다양한 의약품 및 제네릭 의약품의 발견, 개발, 제조 및 판매에 참여하고 있습니다. 이 회사는 전 세계적으로 혁신 의약품 사업부와 바이오시밀러 및 제네릭 의약품 사업부인 산도즈(Sandoz)의 두 사업부를 운영하고 있습니다.

제품 포트폴리오:
클레레온 인공수정체: 이 제품은 첨단 일회용 사전 장착 전달 시스템 광학 유형을 특징으로 합니다. 독창적이고 자동화된 전달 시스템을 통해 이식할 수 있습니다.
주요 개발: 2022년 6월, 노바티스는 안과 약물의 정확한 투여량을 제공하는 혁신적인 아큐스트림(AcuStream) 기술을 보유한 케달리온 테라퓨틱스(Kedalion Therapeutics)를 인수한다고 발표했습니다. 이 인수를 통해 노바티스의 안과 포트폴리오가 확장될 것입니다.
글로벌 시력 관리 기기 시장 보고서는 약 45개 이상의 시장 데이터 표, 40개 이상의 그림 및 약 200페이지 분량의 자료를 제공합니다.

보고서 요약(영어 원문)

Market Overview
The global vision care devices market size was valued at US$ 12.4 billion in 2022 and is estimated to reach US$ 24.78 billion by 2030, growing at a CAGR of 12.7% during the forecast period (2023-2030).
Vision care devices are medical device that is used for enhancing and maintaining vision. These can be surgically embedded inside the socket of the eye permanently or can be used temporarily. These vision care devices can be prescribed or non-prescribed and can be used for an extended period of time.
Market Dynamics
The major factors driving the global vision care devices market are the rising demand for vision care devices owing to increasing incidences of ophthalmic disorders such as glaucoma, age-related macular degeneration (AMD) and cataract, technological advancements and novel product launches.
The increasing awareness initiatives and rising novel technologically advanced vision care devices are expected to drive the market’s growth.
The vision care devices market is driven by rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of ophthalmic disorders such as glaucoma, cataract, AMD and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.
The vision care devices are used for delivering drugs and aesthetic purposes. The adoption of these devices is increasing, leading to rising government initiatives and funds. These funds will help produce vision care devices products such as intraocular lenses, ophthalmic laser or glaucoma drainage devices. The market for these applications is increasing worldwide due to the enhanced number of these ophthalmic disorders. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market’s growth.
Various novel product launches, research studies, and rising awareness initiatives related to these vision care devices contribute to the market’s growth. For instance, in August 2022, STAAR Surgical Company, a designer and provider of implantable lenses and delivery systems, announced its new partnership with Joe Jonas, an actor and singer, to create awareness of its latest implantable Collamer lenses, EVO Visian, an FDA-approved lens for vision correction developed for astigmatism and myopia correction.
Product recalls and stringent regulations associated with the approval of vision care devices are expected to hamper the market’s growth.
Strict rules and regulations for the approval of several devices utilized for vision care is the major factor hindering the growth of the vision care devices market. Various requirements must be fulfilled, leading to an increase in the overall cost of these implants. The high cost and risks involved due to the sensitivity of the organ in the product are likely to hinder the growth.
Market recalls are also a leading factor restraining the growth of the market. Several recalls are taking place due to leakage or complications. For instance, in October 2022, Roche recalled its implant Susvimo due to a manufacturing-related issue. Susvimo is an approved implant that delivers ranibizumab into the eye of people with wet age-related macular degeneration. The septum or seal of the delivery device has some manufacturing issues and cannot keep the medicine from leaking out.
COVID-19 Impact Analysis
The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The Vision Care Devices market has experienced huge losses due to COVID. Key manufacturers have started various research and clinical trials. Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market’s growth. For instance, in July 2020, STAAR Surgical Company, a designer and provider of implantable lenses and delivery systems, announced its novel, innovative implantable Collamer lens, EVO Viva/ EVO Visian ICL, for presbyopia correction, received CE Mark.
Segment Analysis
The Intraocular lenses segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)
The intraocular lenses segment is the highest market holder in the global vision care devices market. The global vision care devices market is segmented based on product type as intraocular lenses, eye-glasses, contact lenses, glaucoma drainage devices, ophthalmic lasers, over-the-counter eye care/ supplements and others. The intraocular lenses segment is the largest market shareholder due to its inherent advantages over other implants or devices, increasing technological advancements and novel product launches.
Intraocular lenses are artificial lenses implanted into the eye for myopia or cataract treatment purposes. It replaces the natural lens of the eye removed during the surgery and restores distant or near vision. These lenses are of various types: accommodating, mono-focal, multifocal, and toric. One of the leading causes of blindness is cataracts which can be treated with the help of these implants through surgery.
The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market’s growth. For instance, in September 2022, Johnson and Johnson Vision, part of Johnson and Johnson Medtech and an eye health company, introduced their novel intraocular lens powered by InteliLight technology and TECNIS symphony OptiBlue intraocular lens for correcting presbyopia. This lens with depth of focus joins the hybrid lens, TECNIS synergy intraocular lens, for spectacle independence in the InteliLight portfolio. This corrects presbyopia in more patients. These deliver low-light performance and superior contrast in this intraocular lens category.
Geographical Analysis
North America holds the largest market share in the global vision care devices market.
North America dominates the global vision care devices market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market’s significant size is attributed to the high medical expenditure.
Increasing expenditure on healthcare and raising awareness among people is also contributing to the market’s growth in this region. Advancement of vision care devices applications in several ophthalmic conditions, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the vision care devices market.
Moreover, the growing number of product launches is responsible for the market’s growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in Aug 2020, Johnson & Johnson Vision, a company focusing on eye health, announced that its TECNIS Eyhance and TECNIS synergy intraocular lenses for cataract treatment got approved by Health Canada and will be available in the Canadian market.
Competitive Landscape
The vision care devices market is highly competitive with local and global companies’ presence. Novartis Inc., Cooper Vision, Johnson & Johnson Services, Inc., STAAR Surgical, Bausch & Lomb Incorporated., Carl Zeiss, Ophtec BV, MORCHER GmbH, Safilo Group S.p.A, EssilorLuxottica and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market’s growth. For instance, in July 2022, Bausch + Lomb Corporation, an eye health company and Sanoculis, an ophthalmic device company, announced their strategic agreements developed to focus on glaucoma’s unmet needs.
Novartis AG
Overview: Novartis is engaged in discovering, developing, manufacturing, and selling a wide range of pharmaceutical and generic medicines. The company has two operating divisions globally: Innovative medicines and Sandoz for biosimilars and generic pharmaceuticals.
Product Portfolio:
Clareon intraocular lens: This has an advanced, disposable and pre-loaded delivery system optic Type. It can be implanted with a delivery system that is unique and automated.
Key Development: In June 2022, Novartis announced its acquisition of Kedalion Therapeutics along with its innovative AcuStream technology, a device that can provide accurate delivery with precise dosing of ophthalmic medications. This acquisition will expand the ophthalmic portfolio of Novartis.
The global vision care devices market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing awareness initiatives for these vision care devices
4.1.1.2. Rising technological advancements
4.1.2. Restraints:
4.1.2.1. Product recalls associated with vision care devices
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1 Porter's Five Forces Analysis
5.2 Supply Chain Analysis
5.3 Pricing Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Intraocular Lenses *
7.2.1. Introduction
7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.2.3. Monofocal IOLs
7.2.4. MultifocalIOLs
7.2.5. Accommodating IOLs
7.2.6. Toric IOLs
7.3. Eye Glasses
7.4. Contact Lenses
7.4.1. Disposable Contact Lenses
7.4.2. Specialty Contact Lenses
7.4.3. Gas Permeable Contact Lenses
7.5. Glaucoma Drainage Devices
7.6. Ophthalmic Lasers
7.7. Over-the-counter Eye Care/ Supplements
7.8. Others
8. By Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.1.2. Market Attractiveness Index, By Type
8.2. Prescription *
8.2.1. Introduction
8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Non-Prescription (Over-the-counter)
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Optical Surgeries *
9.2.1. Introduction
9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.1.1. Glaucoma
9.1.2. Age-related Macular Degeneration
9.1.3. Post-Cataract Surgery
9.1.4. Post Ocular Surgery
9.1.5. Retinal Conditions
9.2. Diagnosis
9.3. Eye Care
9.4. Others
10. By End-User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals *
10.2.1. Introduction
10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Ambulatory Surgical Centers
10.4. Eye Specialty Clinics
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. Competitive Landscape
12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Products Benchmarking
12.4. List of Key Companies to Watch
13. Company Profiles
13.1. Novartis AG *
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. CooperVision
13.3. Johnson & Johnson Services, Inc.
13.4. Alcon
13.5. Bausch & Lomb Incorporated.
13.6. Carl Zeiss
13.7. Ophtec BV
13.8. MORCHER GmbH
13.9. Safilo Group S.p.A
13.10. EssilorLuxottica
LIST NOT EXHAUSTIVE
14. Global Vision Care Devices Market – DataM
14.1. Appendix
14.2. About Us and Application
14.3. Contact Us

언급된 주요 기업들

Novartis AG, CooperVision, Johnson & Johnson Services, Inc., Alcon, Bausch & Lomb Incorporated., Carl Zeiss, Ophtec BV, MORCHER GmbH, Safilo Group S.p.A, EssilorLuxottica

표 목록 (Tables)

List of Tables

Table 1 Global Vision Care Devices Market Value, By Product Type, 2023, 2027 & 2031 ($ Million)

Table 2 Global Vision Care Devices Market Value, By Type, 2023, 2027 & 2031 ($ Million)

Table 3 Global Vision Care Devices Market Value, By Application, 2023, 2027 & 2031 ($ Million)

Table 4 Global Vision Care Devices Market Value, By End-User, 2023, 2027 & 2031 ($ Million)

Table 5 Global Vision Care Devices Market Value, By Region, 2023, 2027 & 2031 ($ Million)

Table 6 Global Vision Care Devices Market Value, By Product Type, 2023, 2027 & 2031 ($ Million)

Table 7 Global Vision Care Devices Market Value, By Product Type, 2022-2031 ($ Million)

Table 8 Global Vision Care Devices Market Value, By Type, 2023, 2027 & 2031 ($ Million)

Table 9 Global Vision Care Devices Market Value, By Type, 2022-2031 ($ Million)

Table 10 Global Vision Care Devices Market Value, By Application, 2023, 2027 & 2031 ($ Million)

Table 11 Global Vision Care Devices Market Value, By Application, 2022-2031 ($ Million)

Table 12 Global Vision Care Devices Market Value, By End-User, 2023, 2027 & 2031 ($ Million)

Table 13 Global Vision Care Devices Market Value, By End-User, 2022-2031 ($ Million)

Table 14 Global Vision Care Devices Market Value, By Region, 2023, 2027 & 2031 ($ Million)

Table 15 Global Vision Care Devices Market Value, By Region, 2022-2031 ($ Million)

Table 16 North America Vision Care Devices Market Value, By Product Type, 2022-2031 ($ Million)

Table 17 North America Vision Care Devices Market Value, By Type, 2022-2031 ($ Million)

Table 18 North America Vision Care Devices Market Value, By Application, 2022-2031 ($ Million)

Table 19 North America Vision Care Devices Market Value, By End-User, 2022-2031 ($ Million)

Table 20 North America Vision Care Devices Market Value, By Country, 2022-2031 ($ Million)

Table 21 South America Vision Care Devices Market Value, By Product Type, 2022-2031 ($ Million)

Table 22 South America Vision Care Devices Market Value, By Type, 2022-2031 ($ Million)

Table 23 South America Vision Care Devices Market Value, By Application, 2022-2031 ($ Million)

Table 24 South America Vision Care Devices Market Value, By End-User, 2022-2031 ($ Million)

Table 25 South America Vision Care Devices Market Value, By Country, 2022-2031 ($ Million)

Table 26 Europe Vision Care Devices Market Value, By Product Type, 2022-2031 ($ Million)

Table 27 Europe Vision Care Devices Market Value, By Type, 2022-2031 ($ Million)

Table 28 Europe Vision Care Devices Market Value, By Application, 2022-2031 ($ Million)

Table 29 Europe Vision Care Devices Market Value, By End-User, 2022-2031 ($ Million)

Table 30 Europe Vision Care Devices Market Value, By Country, 2022-2031 ($ Million)

Table 31 Asia-Pacific Vision Care Devices Market Value, By Product Type, 2022-2031 ($ Million)

Table 32 Asia-Pacific Vision Care Devices Market Value, By Type, 2022-2031 ($ Million)

Table 33 Asia-Pacific Vision Care Devices Market Value, By Application, 2022-2031 ($ Million)

Table 34 Asia-Pacific Vision Care Devices Market Value, By End-User, 2022-2031 ($ Million)

Table 35 Asia-Pacific Vision Care Devices Market Value, By Country, 2022-2031 ($ Million)

Table 36 Middle East & Africa Vision Care Devices Market Value, By Product Type, 2022-2031 ($ Million)

Table 37 Middle East & Africa Vision Care Devices Market Value, By Type, 2022-2031 ($ Million)

Table 38 Middle East & Africa Vision Care Devices Market Value, By Application, 2022-2031 ($ Million)

Table 39 Middle East & Africa Vision Care Devices Market Value, By End-User, 2022-2031 ($ Million)

Table 40 Novartis AG: Overview

Table 41 Novartis AG: Product Portfolio

Table 42 Novartis AG: Key Developments

Table 43 CooperVision: Overview

Table 44 CooperVision: Product Portfolio

Table 45 CooperVision: Key Developments

Table 46 Johnson & Johnson Services, Inc.: Overview

Table 47 Johnson & Johnson Services, Inc.: Product Portfolio

Table 48 Johnson & Johnson Services, Inc.: Key Developments

Table 49 Alcon: Overview

Table 50 Alcon: Product Portfolio

Table 51 Alcon: Key Developments

Table 52 Bausch & Lomb Incorporated.: Overview

Table 53 Bausch & Lomb Incorporated.: Product Portfolio

Table 54 Bausch & Lomb Incorporated.: Key Developments

Table 55 Carl Zeiss: Overview

Table 56 Carl Zeiss: Product Portfolio

Table 57 Carl Zeiss: Key Developments

Table 58 Ophtec BV: Overview

Table 59 Ophtec BV: Product Portfolio

Table 60 Ophtec BV: Key Developments

Table 61 MORCHER GmbH: Overview

Table 62 MORCHER GmbH: Product Portfolio

Table 63 MORCHER GmbH: Key Developments

Table 64 Safilo Group S.p.A: Overview

Table 65 Safilo Group S.p.A: Product Portfolio

Table 66 Safilo Group S.p.A: Key Developments

Table 67 EssilorLuxottica: Overview

Table 68 EssilorLuxottica: Product Portfolio

Table 69 EssilorLuxottica: Key Development

그림 목록 (Figures)

List of Figures

Figure 1 Global Vision Care Devices Market Share, By Product Type, 2022 & 2031 (%)

Figure 2 Global Vision Care Devices Market Share, By Type, 2022 & 2031 (%)

Figure 3 Global Vision Care Devices Market Share, By Application, 2022 & 2031 (%)

Figure 4 Global Vision Care Devices Market Share, By End-User, 2022 & 2031 (%)

Figure 5 Global Vision Care Devices Market Share, By Region, 2022 & 2031 (%)

Figure 6 Global Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 7 Global Vision Care Devices Market Y-o-Y Growth, By Product Type, 2022-2031 (%)

Figure 8 Intraocular Lenses: Global Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 9 Eye-Glasses: Global Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 10 Contact Lenses: Global Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 11 Glaucoma Drainage Devices: Global Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 12 Ophthalmic Lasers: Global Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 13 Over-the-counter Eye Care/ Supplements: Global Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 14 Others: Global Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 15 Global Vision Care Devices Market Y-o-Y Growth, By Type, 2022-2031 (%)

Figure 16 Prescription: Global Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 17 Non-Prescription (Over-the-counter): Global Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 18 Global Vision Care Devices Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 19 Optical Surgeries: Global Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 20 Diagnosis: Global Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 21 Eye Care: Global Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 22 Others: Global Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 23 Global Vision Care Devices Market Y-o-Y Growth, By End-User, 2022-2031 (%)

Figure 24 Hospitals: Global Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 25 Ambulatory Surgical Centers: Global Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 26 Eye Specialty Clinics: Global Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 27 Others: Global Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 28 Global Vision Care Devices Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 29 North America Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 30 North America Vision Care Devices Market Share, By Product Type, 2022 & 2031 (%)

Figure 31 North America Vision Care Devices Market Share, By Type, 2022 & 2031 (%)

Figure 32 North America Vision Care Devices Market Share, By Application, 2022 & 2031 (%)

Figure 33 North America Vision Care Devices Market Share, By End-User, 2022 & 2031 (%)

Figure 34 North America Vision Care Devices Market Share, By Country, 2022 & 2031 (%)

Figure 35 South America Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 36 South America Vision Care Devices Market Share, By Product Type, 2022 & 2031 (%)

Figure 37 South America Vision Care Devices Market Share, By Type, 2022 & 2031 (%)

Figure 38 South America Vision Care Devices Market Share, By Application, 2022 & 2031 (%)

Figure 39 South America Vision Care Devices Market Share, By End-User, 2022 & 2031 (%)

Figure 40 South America Vision Care Devices Market Share, By Country, 2022 & 2031 (%)

Figure 41 Europe Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 42 Europe Vision Care Devices Market Share, By Product Type, 2022 & 2031 (%)

Figure 43 Europe Vision Care Devices Market Share, By Type, 2022 & 2031 (%)

Figure 44 Europe Vision Care Devices Market Share, By Application, 2022 & 2031 (%)

Figure 45 Europe Vision Care Devices Market Share, By End-User, 2022 & 2031 (%)

Figure 46 Europe Vision Care Devices Market Share, By Country, 2022 & 2031 (%)

Figure 47 Asia-Pacific Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 48 Asia-Pacific Vision Care Devices Market Share, By Product Type, 2022 & 2031 (%)

Figure 49 Asia-Pacific Vision Care Devices Market Share, By Type, 2022 & 2031 (%)

Figure 50 Asia-Pacific Vision Care Devices Market Share, By Application, 2022 & 2031 (%)

Figure 51 Asia-Pacific Vision Care Devices Market Share, By End-User, 2022 & 2031 (%)

Figure 52 Asia-Pacific Vision Care Devices Market Share, By Country, 2022 & 2031 (%)

Figure 53 Middle East & Africa Vision Care Devices Market Value, 2022-2031 ($ Million)

Figure 54 Middle East & Africa Vision Care Devices Market Share, By Product Type, 2022 & 2031 (%)

Figure 55 Middle East & Africa Vision Care Devices Market Share, By Type, 2022 & 2031 (%)

Figure 56 Middle East & Africa Vision Care Devices Market Share, By Application, 2022 & 2031 (%)

Figure 57 Middle East & Africa Vision Care Devices Market Share, By End-User, 2022 & 2031 (%)

Figure 58 Novartis AG: Financials

Figure 59 CooperVision: Financials

Figure 60 Johnson & Johnson Services, Inc.: Financials

Figure 61 Alcon: Financials

Figure 62 Bausch & Lomb Incorporated.: Financials

Figure 63 Carl Zeiss: Financials

Figure 64 Ophtec BV: Financials

Figure 65 MORCHER GmbH: Financials

Figure 66 Safilo Group S.p.A: Financials

Figure 67 EssilorLuxottica: Financials

글로벌 시력 관리 기기 시장 – 2023-2030

Global Vision Care Devices Market - 2023-2030